Find Clinical Trial

Home » Find Clinical Trials » A factorial randomised trial of blood pressure lowering with a fixed low-dose perindopril-indapamide combination and intensive glucose control with a modified-release gliclazide-based regimen for the prevention of vascular disease among high risk individuals with type 2 diabetes – ADVANCE

A factorial randomised trial of blood pressure lowering with a fixed low-dose perindopril-indapamide combination and intensive glucose control with a modified-release gliclazide-based regimen for the prevention of vascular disease among high risk individuals with type 2 diabetes – ADVANCE

← Back

Study Phase	Phase 3

Therapeutic Area	Cardiovascular Diseases

Indication	Diabetes - Type II, Hypertension

Sponsor	Institut de Recherches Internationales Servier (I.R.I.S)

Active substance/ Medical device	GLICLAZIDE, INDAPAMIDE, PERINDOPRIL TERT BUTYLAMINE, S005590, S005702

Active Substance Code	S005702, S005590

Protocol Code	CL3-05590-013

EudraCT Code	2005-003281-41

Documents and links

Results summary	READ MORE

Scientific publication	READ MORE

Servier Glossary of Terms

To ease the reading, we are developing a glossary of terms. In this glossary, we provide the lay terms used in our lay summaries and the corresponding medical terms. You will find the Servier Glossary of Terms on this link.